Treatment of Alzheimer's Disease and Related Conditions
申请人:Churcher Ian
公开号:US20100240647A1
公开(公告)日:2010-09-23
Compounds of formula (I) inhibit microtubule affinity regulating kinase (MARK), and hence are suitable for treating diseases associated with abnormal phosphorylation of tau.